Form 4: VolitionRx Secretary's Stock Withholding for Taxes
Insider Transaction Report
VolitionRx Secretary Rodney Rootsaert's Form 4 filing details the withholding of 4,279 shares for tax obligations related to RSU settlement.
Summary
- Rodney Gerard Rootsaert, Secretary of VolitionRx Ltd. (VNRX), reported a change in beneficial ownership.
- On August 1, 2025, 4,279 shares of common stock were disposed of at a price of $0.64 per share.
- This disposition was a withholding by VolitionRx to satisfy tax obligations upon the settlement of 10,190 restricted stock units (RSUs) awarded to Mr. Rootsaert in lieu of cash compensation.
- No shares were sold by Mr. Rootsaert or VolitionRx in this transaction.
- Following this transaction, Mr. Rootsaert directly beneficially owns 134,010 shares and indirectly owns 1,007,718 shares through Concord International, Inc.
Sentiment
Score: 7
Explanation: The filing details a routine tax withholding related to RSU vesting, which is a standard compensation practice and does not indicate any negative operational or financial issues for the company.
Positives
- The transaction represents a routine tax withholding for RSU settlement, not a sale of shares by the executive.
- The underlying event is the vesting of 10,190 restricted stock units, indicating compensation for the reporting person.
Negatives
- The reduction in direct share count is due to tax withholding, not a voluntary sale by the insider.
Risks
- NA
Future Outlook
NA
Management Comments
- The disposition of shares represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 10,190 restricted stock units that were awarded in lieu of cash compensation.
- No shares were sold by the reporting person or VolitionRx in such transaction.
Industry Context
This is a routine insider transaction filing and does not provide information related to broader industry trends or competitors.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| NA | NA | NA | NA | NA |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| NA | NA | NA | NA |
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: Minimal impact as the transaction is a routine tax withholding and not a sale by the insider.
- Employees: The reporting person, as an employee, is receiving compensation through RSU vesting.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 08/01/2025 | Date of transaction (settlement of restricted stock units and tax withholding) |
| 08/05/2025 | Date of filing and signature by reporting person |
Recommendation
holdThe Form 4 filing details a routine insider transaction involving the withholding of shares for tax purposes upon the vesting of restricted stock units. This is a standard compensation event and does not provide new information that would warrant a change in investment recommendation for VolitionRx Ltd. (VNRX).
Keywords
VolitionRx, VNRX, Form 4, insider transaction, stock withholding, restricted stock units, RSU, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.